Literature DB >> 9422992

Expression of neural BC200 RNA in human tumours.

W Chen1, W Böcker, J Brosius, H Tiedge.   

Abstract

BC200 RNA is a 200-nucleotide-long non-messenger RNA that is selectively expressed in the primate nervous system, where it has been identified in somatodendritic domains of a subset of neurons. BC200 RNA is not normally expressed in non-neuronal somatic cells; it has been shown, however, to be expressed in germ cells and in cultured immortal cell lines of various non-neural origins. In order to investigate whether the neuron-specific expression of BC200 RNA is also deregulated during tumourigenesis in non-neural human tissues, 80 different tumour specimens, representing 19 different tumour types, were screened for the presence of the RNA. BC200 RNA was expressed in carcinomas of the breast, cervix, oesophagus, lung, ovary, parotid, and tongue, but not in corresponding normal tissues. BC200 RNA was not detectable in bladder, colon, kidney, or liver carcinoma tissues examined in this study. These results demonstrate that BC200 expression is deregulated under certain neoplastic conditions. The expression of BC200 RNA in non-neural tumours may indicate a functional interrelationship with induction and/or progression of such tumours.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9422992     DOI: 10.1002/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  94 in total

1.  Cis-acting influences on Alu RNA levels.

Authors:  C Alemán; A M Roy-Engel; T H Shaikh; P L Deininger
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

Review 2.  RNA polymerase III transcription: its control by tumor suppressors and its deregulation by transforming agents.

Authors:  T R Brown; P H Scott; T Stein; A G Winter; R J White
Journal:  Gene Expr       Date:  2000

Review 3.  Noncoding RNAs involved in mammary gland development and tumorigenesis: there's a long way to go.

Authors:  Amy N Shore; Jason I Herschkowitz; Jeffrey M Rosen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-03-09       Impact factor: 2.673

Review 4.  Long non-coding RNAs and cancer: a new frontier of translational research?

Authors:  R Spizzo; M I Almeida; A Colombatti; G A Calin
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

5.  Transformation by E1A oncoprotein involves ubiquitin-mediated proteolysis of the neuronal and tumor repressor REST in the nucleus.

Authors:  Hancheng Guan; Robert P Ricciardi
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

6.  Altered expression of long non-coding RNAs during genotoxic stress-induced cell death in human glioma cells.

Authors:  Qian Liu; Shanquan Sun; Wei Yu; Jin Jiang; Fei Zhuo; Guoping Qiu; Shiye Xu; Xuli Jiang
Journal:  J Neurooncol       Date:  2015-02-03       Impact factor: 4.130

7.  Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation.

Authors:  Sandra A S Johnson; Louis Dubeau; Deborah L Johnson
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

8.  Induction of neuronal and tumor-related genes by adenovirus type 12 E1A.

Authors:  Hancheng Guan; Jim F Williams; Robert P Ricciardi
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

9.  tRNA over-expression in breast cancer and functional consequences.

Authors:  Mariana Pavon-Eternod; Suzanna Gomes; Renaud Geslain; Qing Dai; Marsha Rich Rosner; Tao Pan
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

10.  RNAi and cancer: Implications and applications.

Authors:  Maen Abdelrahim; Stephen Safe; Cheryl Baker; Ala Abudayyeh
Journal:  J RNAi Gene Silencing       Date:  2006-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.